You just read:

Safety Review Committee Approves the Continued Evaluation of the 20 MBq/kg Betalutin® with 100 mg/m2 Lilotomab Regimen in Phase 2 Cohort in NHL

News provided by

Nordic Nanovector

May 19, 2017, 11:22 ET